Lin Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lin Lin has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Andrew C. Chang
Department of Surgery, University of Michigan, Ann Arbor, Michigan
4 shared publications Dafydd G. Thomas
Department of Pathology, University of Michigan, Ann Arbor, MI, USA
4 shared publicationsMark B. Orringer
Section of Thoracic Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI, USA
4 shared publicationsZhuwen Wang
Section of Thoracic Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI, USA
4 shared publications- David G. Beer
Department of Surgery, Section of Thoracic Surgery, University of Michigan Medical School, Ann Arbor, Michigan
3 shared publications Jules Lin
Section of Thoracic Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI, USA
3 shared publications
Latest Publications
- Open Access
- 1 June 2015
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (26) , 22239-22257
Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma
Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma
- 1 June 2015
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (26) , 22239-22257
Open AccessOsteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma
Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma
- Open Access
- 28 February 2012
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 109 (11) , 4251-4256
Activation of GATA binding protein 6 ( GATA6 ) sustains oncogenic lineage-survival in esophageal adenocarcinoma
Gene amplification is a tumor-specific event during malignant transformation. Recent studies have proposed a lineage-dependency (addiction) model of human cancer whereby amplification of certain lineage transcription factors predisposes a survival mechanism in tumor cells. These tumor cells are derived from tissues where the lineage factors play essential developmental and maintenance roles. Here, we show that recurrent amplification at 18q11.2 occurs in 21% of esophageal adenocarcinomas (EAC). Utilization of an integrative genomic strategy reveals a single gene, the embryonic endoderm transcription factor GATA6 , as the selected target of the amplification. Overexpression of GATA6 is found in EACs that contain gene amplification. We find that EAC patients whose tumors carry GATA6 amplification have a poorer survival. We show that ectopic expression of GATA6 , together with FGFR2 isoform IIIb, increases anchorage-independent growth in immortalized Barrett's esophageal cells. Conversely, siRNA-mediated silencing of GATA6 significantly reduces both cell proliferation and anchorage-independent growth in EAC cells. We further demonstrate that induction of apoptotic/anoikis pathways is triggered upon silencing of GATA6 in EAC cells but not in esophageal squamous cells. We show that activation of p38α signaling and up-regulation of TNF-related apoptosis-inducing ligand are detected in apoptotic EAC cells upon GATA6 deprivation. We conclude that selective gene amplification of GATA6 during EAC development sustains oncogenic lineage-survival of esophageal adenocarcinoma.
- 28 February 2012
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 109 (11) , 4251-4256
Open AccessActivation of GATA binding protein 6 ( GATA6 ) sustains oncogenic lineage-survival in esophageal adenocarcinoma
Gene amplification is a tumor-specific event during malignant transformation. Recent studies have proposed a lineage-dependency (addiction) model of human cancer whereby amplification of certain lineage transcription factors predisposes a survival mechanism in tumor cells. These tumor cells are derived from tissues where the lineage factors play essential developmental and maintenance roles. Here, we show that recurrent amplification at 18q11.2 occurs in 21% of esophageal adenocarcinomas (EAC). Utilization of an integrative genomic strategy reveals a single gene, the embryonic endoderm transcription factor GATA6 , as the selected target of the amplification. Overexpression of GATA6 is found in EACs that contain gene amplification. We find that EAC patients whose tumors carry GATA6 amplification have a poorer survival. We show that ectopic expression of GATA6 , together with FGFR2 isoform IIIb, increases anchorage-independent growth in immortalized Barrett's esophageal cells. Conversely, siRNA-mediated silencing of GATA6 significantly reduces both cell proliferation and anchorage-independent growth in EAC cells. We further demonstrate that induction of apoptotic/anoikis pathways is triggered upon silencing of GATA6 in EAC cells but not in esophageal squamous cells. We show that activation of p38α signaling and up-regulation of TNF-related apoptosis-inducing ligand are detected in apoptotic EAC cells upon GATA6 deprivation. We conclude that selective gene amplification of GATA6 during EAC development sustains oncogenic lineage-survival of esophageal adenocarcinoma.
- Open Access
Expression and Effect of Inhibition of the Ubiquitin-Conjugating Enzyme E2C on Esophageal Adenocarcinoma
- 30 November 2005
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 45 (4) , 319-331
Multiple forms of genetic instability within a 2‐Mb chromosomal segment of 3q26.3–q27 are associated with development of esophageal adenocarcinoma
Gene amplification is one of the mechanisms to activate oncogenes in many cancers, including esophageal adenocarcinoma (EA). In the present study, we used two‐dimensional restriction landmark genome scanning to clone a NotI/DpnII fragment that showed increased genomic dosage in 1 of 44 EAs analyzed. This fragment maps to 3q26.3–q27, and subsequent experiments identified two intrachromosomal amplicons within a 10‐Mb DNA segment in 7 of 75 (9%) EAs. The distal amplified‐core region maps centromeric to the PIK3CA locus, and a microsatellite (D3S1754) within this region exhibited significant instability (MSI), in stark contrast to the genomewide microsatellite stability found in EA. D3S1754‐MSI arises in premalignant Barrett's dysplastic cells and preceded amplification of the nascent MSI allele in the corresponding EA. Seven ESTs within the amplified‐core were overexpressed in amplicon‐containing EAs. One of these, EST AW513672, represents a chimeric transcript that initiated from an antisense promoter sequence in the 5′UTR of a full‐length LINE‐1 element (L1‐5′ASP). Similar chimeric transcripts encoding portions of the MET oncogene and the BCAS3 gene also were overexpressed in EAs, suggesting that L1‐5′ASP activation may occur at a broad level in primary EAs. Thus, the fine dissection of a 2‐Mb amplified DNA segment in 3q26.3–q27 in EA revealed multiple genetic alterations that had occurred sequentially and/or concurrently during EA development. This article has supplementary material, available at http://www.interscience.wiley.com/jpages/1045‐2257/suppmat.
- 30 November 2005
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 45 (4) , 319-331
Multiple forms of genetic instability within a 2‐Mb chromosomal segment of 3q26.3–q27 are associated with development of esophageal adenocarcinoma
Gene amplification is one of the mechanisms to activate oncogenes in many cancers, including esophageal adenocarcinoma (EA). In the present study, we used two‐dimensional restriction landmark genome scanning to clone a NotI/DpnII fragment that showed increased genomic dosage in 1 of 44 EAs analyzed. This fragment maps to 3q26.3–q27, and subsequent experiments identified two intrachromosomal amplicons within a 10‐Mb DNA segment in 7 of 75 (9%) EAs. The distal amplified‐core region maps centromeric to the PIK3CA locus, and a microsatellite (D3S1754) within this region exhibited significant instability (MSI), in stark contrast to the genomewide microsatellite stability found in EA. D3S1754‐MSI arises in premalignant Barrett's dysplastic cells and preceded amplification of the nascent MSI allele in the corresponding EA. Seven ESTs within the amplified‐core were overexpressed in amplicon‐containing EAs. One of these, EST AW513672, represents a chimeric transcript that initiated from an antisense promoter sequence in the 5′UTR of a full‐length LINE‐1 element (L1‐5′ASP). Similar chimeric transcripts encoding portions of the MET oncogene and the BCAS3 gene also were overexpressed in EAs, suggesting that L1‐5′ASP activation may occur at a broad level in primary EAs. Thus, the fine dissection of a 2‐Mb amplified DNA segment in 3q26.3–q27 in EA revealed multiple genetic alterations that had occurred sequentially and/or concurrently during EA development. This article has supplementary material, available at http://www.interscience.wiley.com/jpages/1045‐2257/suppmat.